In Vitro Biological Reagents
ID: NOI-NIAID-25-2252017Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/8bdb96960d7140a6980aa33ecd6e6665/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source procurement with Becton, Dickinson and Company for various in vitro biological reagents essential for research purposes. The procurement includes specific quantities of antibodies and reagents, such as Hu CD183 BV711 and Hu IL-13 BV421, along with shipping and handling to be delivered to Gaithersburg, Maryland. This procurement is justified under the authority of 41 U.S.C. 1901 (a)(1), indicating that only one responsible source can meet the agency's requirements. Interested parties may submit a capability statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 30, 2024, with all submissions considered at the Government's discretion. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.

    Point(s) of Contact
    Leah Hinson
    leah.hinson@nih.gov
    Files
    Title
    Posted
    2_2252017_NOI.pdf
    The National Institute of Allergy and Infectious Diseases (NIAID) has issued a Notice of Intent (NOI-NIAID-25-2252017) to negotiate a sole source procurement with Becton, Dickinson and Company for specific biomedical products required for research purposes. The needed items include various reagents and antibodies, with specified quantities and product numbers. Shipping and handling will be included in this procurement, which will be delivered to Gaithersburg, MD. This notice is set under the authority of 41 U.S.C. 1901 (a)(1), as only one responsible source can fulfill the agency's requirements. While no formal request for proposal (RFP) is being made, other interested parties may submit a capability statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 30, 2024. The decision to consider competing submissions lies solely with the Government, highlighting the exclusive nature of this procurement process.
    Lifecycle
    Title
    Type
    In Vitro Biological Reagents
    Currently viewing
    Special Notice
    Similar Opportunities
    Brand Name Biological Product
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a brand name biological product under solicitation number RFQ-NIAID-25-2251721. The procurement involves the acquisition of specific biological supplies, including various anti-human antibodies, to support the National Institute of Allergy and Infectious Diseases (NIAID) in its research efforts. These products are critical for advancing biomedical research and ensuring the availability of high-quality reagents for scientific studies. Interested vendors must submit their offers by December 22, 2024, at 10:00 AM EST, and can direct inquiries to Calvin Robinson at calvin.robinson@nih.gov.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    Support Plan for a Stellaris 8 Confocal Microscope (S/N 8300000444)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Leica Microsystems Inc. for a 12-month renewal Support Plan for a Stellaris 8 Confocal Microscope (S/N 8300000444), with two optional one-year extensions. The procurement aims to secure a comprehensive maintenance agreement that includes unlimited service visits by trained engineers, OEM replacement parts, annual planned maintenance, and access to expert support, ensuring the microscope operates at optimal performance levels. This equipment is crucial for research and diagnostics in the field of allergy and infectious diseases, highlighting the importance of maintaining its functionality. Interested vendors must submit capability statements by 10:00 AM EST on December 30, 2024, through the NIAID electronic Simplified Acquisition Submission System (eSASS), with all required documentation to be included for consideration.
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for biomarkers abeta42, abeta40, and pTau 217, which will be utilized in research involving stored samples from the Baltimore Longitudinal Study of Aging (BLSA) to assess cognitive decline and neurodegeneration. This procurement is critical for advancing Alzheimer’s research and will be awarded as a firm fixed-price purchase order, with quotations due by 5:00 p.m. Eastern Time on January 8, 2025. Interested vendors should contact Iris Merscher at iris.merscher@nih.gov for further details.
    Notice of Intent for 1800 NEXGEN Cages with Clear High Temperature Polysulfone Plastic
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Allentown LLC for the procurement of specialized laboratory equipment. The requirement includes 50 units of the 1800 NEXGEN cages made from clear high-temperature polysulfone plastic, along with 50 external bottle tops designed for rat use, featuring dual pockets and various enhancements for research applications. This procurement is critical for supporting ongoing research efforts, as the specified items are tailored to meet unique laboratory needs that only Allentown LLC can fulfill. Interested vendors may submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 27, 2024, at 10:00 AM, with all submissions considered by the Government at its discretion. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.
    Cytiva Sefia S-2000 Cell Processing Instrument Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source contract to Global Life Sciences Solutions USA LLC for preventative maintenance services on three Cytiva Sefia S-2000 Cell Processing Instruments located at the NIH Clinical Center in Bethesda, Maryland. The contract will cover unlimited service repair and preventive maintenance for these critical instruments used in cell therapy manufacturing and research, which are essential for compliance with FDA regulations regarding the maintenance of equipment used in drug product manufacturing. Interested parties capable of providing similar services may submit a capability statement by December 29, 2024, at 12:00 pm EST to Sheri Eiri at sheri.eiri@nih.gov for consideration in the procurement process.
    CHROMIUM IX/X AND VISIUM CYTASSIT ASSURANCE PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a sole-source contract with 10X Genomics, Inc. for a warranty and maintenance agreement for their Chromium X and CytAssist instruments. This procurement is critical as these instruments are essential for conducting advanced single-cell sequencing and spatial transcriptomics research, which supports the development of new diagnostics, therapeutics, and vaccines against human diseases. The maintenance agreement will ensure uninterrupted operation of these technologies, which are vital for NIAID researchers, and interested vendors must submit their capabilities statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on December 30, 2024. For further inquiries, vendors can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D. Weidow at weidowjd@niaid.nih.gov.
    Global Life Sciences Solutions Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract for preventative maintenance services for three Sepax Pro Cell Processing Systems used in cell therapy manufacturing and research. The contract will be awarded to Global Life Sciences Solutions USA LLC, the only vendor authorized to perform these services due to the proprietary nature of the equipment and the requirement for compliance with FDA regulations regarding critical equipment maintenance. The period of performance for this contract is set from January 27, 2025, to January 26, 2026, with interested parties encouraged to submit capability statements by December 28, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.
    6550--RFI: NOI SS Reagents for BioFire Analyzer
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a Special Notice for a Sole Source contract to procure reagents for the BioFire Analyzer from BIOMERIEUX INC. This contract, structured as a Firm-Fixed Price delivery order, will span one year and is intended to support the medical needs of the Michael E. DeBakey VA Medical Center in Houston, Texas. The reagents are critical for in vitro diagnostics, ensuring safe handling and timely reporting in compliance with VA regulations. Interested vendors are encouraged to submit information regarding their capabilities by the specified deadline, and inquiries can be directed to Contracting Officer Shasta Britt at shasta.britt@va.gov or by phone at 713-794-8609.